Endocarditis-TR: Diagnosis, treatment, and prognosis of the infective endocarditispatients admitting tertiary centres of Turkey

dc.contributor.authorCalik, Ali Nazmi
dc.contributor.authorOzluk, Fatma Ozlem Arican
dc.contributor.authorKaratas, Mehmet Baran
dc.contributor.authorCanga, Yigit
dc.contributor.authorEren, Semih
dc.contributor.authorAyhan, Gorkem
dc.contributor.authorSunbul, Ayse
dc.contributor.authorPalice, Ali
dc.contributor.authorCandemir, Aytac
dc.contributor.authorAkyuz, Sukru
dc.contributor.authorZoghi, Mehdi
dc.contributor.authorKozan, Omer
dc.contributor.pubmedID36161622en_US
dc.date.accessioned2022-12-14T12:31:18Z
dc.date.available2022-12-14T12:31:18Z
dc.date.issued2022
dc.description.abstractBackground/aim: Infective endocarditis (IE) is still a significant cause of morbidity and mortality among cardiovascular diseases. ENDOCARDITIS-TR study aims to evaluate the compliance of the diagnostic and therapeutic methods being used in Turkey with current guidelines. Materials and methods: The ENDOCARDITIS-TR trial is a multicentre, prospective, observational study consisting of patients admitted to tertiary centres with a definite diagnose of IE. In addition to the demographic, clinical, microbiological, and echocardiographic findings of the patients, adverse events, indications for surgery, and in-hospital mortality were recorded during a 2-year time interval. Results: A total of 208 IE patients from 7 tertiary centres in Turkey were enrolled in the study. The study population included 125 (60.1%) native valve IE (NVE), 65 (31.3%) prosthetic IE (PVIE), and 18 (8.7%) intracardiac device-related IE (CDRIE). One hundred thirty-five patients (64.9%) were culture positive, and the most frequent pathogenic agent was methicillin-susceptible Staphylococcus aureus (MSSA) (18.3%). Among 155 (74.5%) patients with an indication for surgery, only 87 (56.1%) patients underwent surgery. The all-cause mortality rate was 29.3% in-hospital follow-up. Multivariable Cox regression analysis revealed that absence of surgery when indicated (HR: 3.29 95% CI: 0.93-11.64 p = 0.05), albumin level at admission (HR: 0.46 95% CI: 0.29-0.73 P < 0.01), abscess formation (HR: 2.11 95% CI: 1.01-4.38 p = 0.04) and systemic embolism (HR: 1.78 95% CI: 1.05-3.02 p = 0.03) were ascertained independent predictors of in-hospital all-cause mortality. Conclusion: The short-term results of the ENDOCARDITIS-TR trial showed the high frequency of staphylococcal IE, relatively high in-hospital mortality rates, shortage of surgical treatment despite guideline-based surgical indications and low usage of novel imaging techniques. The results of this study will provide a better insight to physicians in respect to their adherence to clinical practice guidelines.en_US
dc.identifier.endpage455en_US
dc.identifier.issn1300-0144en_US
dc.identifier.issue2en_US
dc.identifier.startpage445en_US
dc.identifier.urihttps://journals.tubitak.gov.tr/cgi/viewcontent.cgi?article=5332&context=medical
dc.identifier.urihttp://hdl.handle.net/11727/8295
dc.identifier.volume52en_US
dc.identifier.wos000804954400020en_US
dc.language.isoengen_US
dc.relation.isversionof10.55730/1300-0144.5332en_US
dc.relation.journalTURKISH JOURNAL OF MEDICAL SCIENCESen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergien_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectInfective endocarditisen_US
dc.subjectin-hospital mortalityen_US
dc.subjectheart valve diseaseen_US
dc.titleEndocarditis-TR: Diagnosis, treatment, and prognosis of the infective endocarditispatients admitting tertiary centres of Turkeyen_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
ds196.pdf
Size:
837.92 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: